Histone deacetylase (HDAC) inhibitors- based drugs are effective to control Mycobacterium tuberculosis infection and promote the sensibility for rifampicin in MDR strain

Memórias do Instituto Oswaldo Cruz

DOI

10.1590/0074-02760230143

Autores

Rodríguez-Carlos

García-Hernández

De Jesus-Gonzalez

Palavras-chave

drug repositioning

innate immunity

histone deacetylase inhibitors

multidrug-resistant

Mycobacterium tuberculosis

Edição

Memorias IOC v. 118 (2023)

Identificação

Arquivo

https://www.scielo.br/j/mioc/a/zRNFdpD4xyZz5zVzc7t4VfG/?lang=en&format=pdf

Página da publicação

https://www.scielo.br/j/mioc/a/zRNFdpD4xyZz5zVzc7t4VfG/abstract/?lang=en

Publicado por (Instituto)